The Prescription Drug User Fee Act target guidelines for NDA resubmissions include acknowledgment of acceptance for review within 30 days of submission, and completion of submission review within 6 ...
The note, which the Department of Justice released, said it was investigating, and then declared fake, was postmarked three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback